BioCorRx (BICX) Net Cash Flow Growth (3y) (2013 - 2026)
BioCorRx (BICX) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -10.31% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 42.82% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | -34.83% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | -2.81% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 49.32% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | -67.79% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 18.85% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | -53.08% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 4.36% |
| 10 | BioCorRx | - | - | 189,355.00 | -18.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.71% |
| Dec 31, 2025 | -214.69% |
| Sep 30, 2025 | 78.30% |
| Jun 30, 2025 | 41.99% |
| Mar 31, 2025 | -35.75% |
| Dec 31, 2024 | 28.73% |
| Sep 30, 2024 | -29.97% |
| Jun 30, 2024 | 57.49% |
| Mar 31, 2024 | -69.92% |
| Dec 31, 2023 | 35.77% |
| Sep 30, 2023 | 57.37% |
| Jun 30, 2023 | 76.73% |
| Mar 31, 2023 | 30.06% |
| Dec 31, 2022 | 26.11% |
| Sep 30, 2022 | 66.03% |
| Jun 30, 2022 | -26.44% |
| Mar 31, 2022 | 35.50% |
| Dec 31, 2021 | -176.66% |
| Sep 30, 2021 | 28.62% |
| Jun 30, 2021 | -58.68% |